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This study examined attitudes to human papillomavirus (HPV) testing among a purposively selected sample of women from four
ethnic groups: white British, African Caribbean, Pakistani and Indian. The design was qualitative, using focus group discussion to elicit
women’s attitudes towards HPV testing in the context of cervical cancer prevention. The findings indicate that although some women
welcomed the possible introduction of HPV testing, they were not fully aware of the sexually transmitted nature of cervical cancer
and expressed anxiety, confusion and stigma about HPV as a sexually transmitted infection. The term ‘wart virus’, often used by
medical professionals to describe high-risk HPV to women, appeared to exacerbate stigma and confusion. Testing positive for HPV
raised concerns about women’s sexual relationships in terms of trust, fidelity, blame and protection, particularly for women in long-
term monogamous relationships. Participation in HPV testing also had the potential to communicate messages of distrust, infidelity
and promiscuity to women’s partners, family and community. Concern about the current lack of available information about HPV was
clearly expressed and public education about HPV was seen as necessary for the whole community, not only women. The
management of HPV within cervical screening raises important questions about informed participation. Our findings suggest that HPV
testing has the potential to cause psychosocial harm to women and their partners and families.
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Major changes are taking place in cervical screening. The
development of sensitive and cost-effective tests for high-risk
types of the human papillomavirus (HPV) (Cuzick and Sasieni,
1997; Kim et al, 2002; Mandelblatt et al, 2002), the primary causal
agent of cervical cancer (Munoz et al, 1992; Schiffman, 1993; Bosch
et al, 1995), suggests that HPV testing in triage and primary
screening may be a feasible and attractive adjunct to conventional
cytological screening (Cuzick et al, 2000; Solomon et al, 2001;
Sasieni and Cuzick, 2002). The UK Department of Health, the
Medical Research Council/National Health Service and the US
National Cancer Institute are currently running trials of HPV
screening for women at triage (UK National Screening Committee,
2000; Schiffman and Adrianza, 2000). Results of the US trial
have recently been published and provide support for HPV testing
among women with borderline smears (atypical cells of undeter-
mined significance, ASCUS) (Solomon et al, 2001; Stoler, 2002;
Sherman et al, 2002). In response, the Bethesda 2001 Consensus
Guidelines for the Management of Women with Cervical
Cytological Abnormality have recommended HPV testing for
women with ASC-US (ASCUS) (Wright et al, 2002). Pressure to
adopt HPV testing within cervical screening in the UK and other
countries is steadily increasing.
Although HPV testing in cervical screening offers potential
public health benefits, it also raises some difficult issues for women
who undergo screening. As a sexually transmitted infection (STI),
HPV is extremely common among the sexually active population,
but awareness of the role of the virus may bring stigma to cervical
cancer, and resurrect social and psychological barriers to screening
that impact negatively on women. Screening for a sexually
transmitted agent has important implications (Duncan et al,
2001), with particular significance for those in long-term mono-
gamous relationships or within groups where lifelong monoga-
mous relationships are more strongly advocated, such as some
religious and ethnic minority groups (Elam et al, 1999). To date
there have been few studies examining psychosocial implications
of HPV testing and none with women of varying ethnicity.
This study examines attitudes to HPV testing within primary
cervical screening among a sample of women purposively selected
to provide contrasting religious and cultural beliefs and practices,
which could influence attitudes and experiences related to HPV
testing. Since the impact of HPV testing is under-researched, may
be complex, and importantly is unpredictable, a qualitative
methodology was selected to explore the diversity of issues
surrounding HPV using an approach grounded in participants’
perspectives.
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Participants
A total of 71 women (aged 20–59 years) eligible for cervical
screening within Greater Manchester were recruited from social
and community groups by ethnically matched community
researchers, who conducted focus group discussions. Participants
from four ethnic groups (self-identified as white British, African
Caribbean, Indian and Pakistani), varying in age, marital/partner
status and socioeconomic position (measured via education), were
selected using principles of purposive sampling, a method of
nonrandom sampling of participants possessing certain character-
istics, to provide a range of demographic backgrounds and
experiences of interest to the research area (see Table 1). Ethical
approval for the study was given by the Manchester Local Research
Ethics Committees. Women with any history of cervical intrae-
pithelial neoplasia (CIN) or with a previous total hysterectomy
were excluded from the study.
Focus groups
Eight focus groups were conducted (two per ethnic group, each
group met only once), during July and September 2000, in English,
Gujarati or Urdu as appropriate. The group discussions were
tape-recorded, transcribed verbatim and translated into English
where necessary. To ensure that all participants had the same baseline
knowledge, basic information about cervical cancer and screening,
and detailed information about HPV testing was provided at the
beginning of the discussion session. Information about HPV
concerned high-risk types associated with cervical cancer and
covered viral transmission, latency, prevalence and association
with CIN, and included information about the potential utility of
HPV testing within primary cervical screening. All information
was approved by clinical specialists (AS and MD). Core questions
explored attitudes towards HPV testing covering: reactions to HPV
as an STI linked to cervical cancer; anticipated reactions to testing
positive for HPV; partner, family and community attitudes to HPV
testing, and religious and cultural influences.
Analysis
Data were analysed using framework analysis (Ritchie and
Spencer, 1994). This is a matrix-based approach to qualitative
data analysis. The transcripts were examined by two authors (KM
and SF) to identify emergent themes and to develop the framework
analytic structure. The FA technique involves identifying recurring
and important themes based on a combination of a priori issues,
emergent issues and recurring attitudes or experiences. Once the
first themes are identified they are applied to further transcripts
where they are refined so that they encapsulate the diversity of
participants’ experiences.
RESULTS
Upset, stigma and confusion
Women expressed ‘worry’, ‘shock’, ‘surprise’ and even ‘fear’ in
response to the information that cervical cancer was linked to a
sexually transmitted virus. Responses were set against a back-
ground in which cervical cancer itself was perceived as a ‘serious’
and frightening disease. Few women were fully aware of the
sexually transmitted nature of cervical cancer. There was confu-
sion between high-risk HPV types (often called the ‘wart virus’ by
medical professionals) and other HPV types such as genital warts
or plantar warts. Women described concern about transmission of
infection from warts on hands to the genital and cervical area
during sex, and questioned the impact of these and other HPV
types (e.g. genital warts) to their risk of CIN.
The stigma associated with STIs was implicit in women’s
dramatic reactions to HPV testing and was similar across all of the
Table 1 Sociodemographic characteristics
African-Caribbean (n) Indian (n) Pakistani (n) White British (n) Total n (%)
Mean age 35 43 41 39 40
(range) (20–58) (20–59) (31–56) (26–55) (20–59)
Born in UK
Yes 10 2 3 15 30 (42.9)
No 6 17 17 1 41 (58.1)
Country of education
UK 10 1 4 16 28 (43.1)
Outside UK 3 18 15 0 33 (50.8)
Both 3 0 1 0 4 (6.2)
Age left full-time education
15 and under 5 1 2 3 11 (15.5)
16–18 6 7 8 12 33 (46.5)
19 and over 5 10 9 1 25 (35.2)
Missing 0 1 1 0 2 (2.8)
Marital status
Married/living with partner 2 15 15 12 44 (62)
Single 12 2 3 3 20 (28.2)
Divorced/separated/widowed 2 2 2 1 7 (9.8)
Ever attended a smear test
Yes 16 17 18 15 66 (93.0)
No 0 2 2 1 5 (7.0)
Total interviewed sample 16 19 20 16 71
Attitudes to HPV testing
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lethnic groups studied. Reactions such as ‘I would cry for a month’
and ‘panic’ indicate the strong negative emotional response to
HPV as an STI. Stigma was explicitly mentioned by some women,
who highlighted the negative connotations of the term ‘wart’,
particularly its link with genital warts (symptomatic types, visible
to the naked eye), which seemed to have a long-standing stigma as
an STI, and also with other types of wart. ‘Warts’ in any form were
viewed as unpleasant and unwanted, and these perceptions were
described as being rooted in early childhood experience that
involved others avoiding contact and exclusion from physical
education activities carried out barefoot (Box 1).
Impact of testing positive for HPV
Women were asked how they would feel if they tested positive for
HPV. Participants in all groups described their reactions in terms
of anger, distress and anxiety. They also raised questions such as
who the infection came from, and when. Some women also
demonstrated more positive views about testing, including feeling
relieved that ‘something’ could be found at an ‘early stage’, which
was viewed as more amenable to effective treatment. Some
respondents balanced the psychological costs of testing, in terms
of anxiety, distress and worries about their relationship, against
the physical benefits of efficient early detection, and the
psychological benefits of reassurance following testing. These
more positive views were only expressed by women in the African-
Caribbean and white British groups. In the Indian and Pakistani
groups, emphasis was given to the psychological costs of screening
in terms of anxiety and stress, and relationship difficulties
following a positive result (Box 2).
Testing positive for HPV raised challenging issues concerning
participants’ relationships. Issues of trust, blame, sex and fidelity,
and protection emerged as key themes in women’s explanations.
These themes featured in the accounts of women from all ethnic
and socioeconomic groups.
(i) Trust. Trust emerged strongly with deep concerns expressed
over trust being ‘broken’ between women and their sexual
partners/spouses.
(ii) Blame. Who was to blame for the infection dominated
responses to testing HPV positive. Women described anticipating
feelings of ‘anger’, ‘hurt’ and ‘suspicion’ towards their current
sexual partner and questioned the history of previous sexual
partners. Women, particularly those in the Indian and Pakistani
groups, also expressed serious concern and, in some cases, fear
that their partner might attribute the blame for HPV infection to
them, irrespective of their own previous sexual behaviour.
(iii) A test of fidelity. It was suggested by women in the Indian
and Pakistani groups that the test might be used as a test of
faithfulness, ‘we will know if our husbands are being faithful or
not’, and an indicator of how much their partners ‘care’.
(iv) Protection. Among women in all the ethnic groups studied,
the prospect of testing HPV positive raised questions about
protection and safe sex behaviour. Women were told in the study
information that protection offered by condoms was uncertain, yet
they still identified condoms as the means to protect themselves
from HPV. The prospect of using condoms raised worries about
the complexities involved in suggesting condom use to partners,
which could be perceived as indicating ‘mistrust’ and ‘suspicion’,
particularly among women with long-term partners/spouses. It was
also suggested that becoming HPV positive, after making a
deliberate and emotionally costly effort to use condoms, would
add to women’s feelings of frustration and helplessness. Abstaining
from sex completely was suggested by a few women as a possible
strategy for preventing HPV: ‘why bother to have sex when you
know it may cause you a problem?’
Communicating unwanted messages
Attending for HPV testing and testing positive for HPV were
identified as potentially communicating unwanted messages to
one’s partner, family and community.
Mistrust and infidelity Women from all the groups, but notably
Indian and Pakistani women, highlighted the messages of distrust
or infidelity that may be conveyed to one’s partner by simply
attending screening, particularly for women in long-term mono-
gamous relationships.
Promiscuity Attending screening or testing positive for HPV was
also suggested as implying promiscuity and sexual activity to
others such as family (particularly parents) and friends, for women
in all the groups. Women from the Indian and Pakistani groups
suggested that there may be denial that HPV testing is necessary,
with their communities viewed as not at risk of sexually trans-
mitted disease. However, such views were not considered to be
held universally and were attributed to older family or community
members and less relevant for ‘educated’ men and women.
Nontraditional beliefs and practices For the Indian and Pakistani
women, testing was also perceived to reflect nontraditional cultural
or religious practices concerning sex and monogamy to their
family and community. Muslim beliefs were described by some of
Box 1 Reactions to HPV information
HPV as an STI
‘Women will get frightened and scared. The word cancer is scary enough and
now this new wart virus will cause many of us to be wary’
Confusion
‘If somebody has warts, whatever sortyare you at any more risk of this
particular virusythey’re all from the same family and if somebody has this
little thing on his finger?’
Stigma
‘I will be heartbroken and worried for my health and for my family’
‘I think warts in general have a cross on them’
Box 2 Testing positive for HPV
Reactions to results
‘After the initial shock you will wonder how and when it happened and was it
before your marriage?’
‘It would reassure me I suppose, if I hadn’t had it done, I wouldn’t know if I’d got
it and it could be another 3–4 years before I had my smear done. So I’m closer
to having treatment’
Trust
‘I will mistrust my husband’
‘It makes you suspicious of him’
Blame
‘You will feel like killing him’
‘If I tested positive, I would worry who I had slept with’
‘My husband will deny giving it to me and will accuse me of sleeping with
someone else’
Test of fidelity
‘If my partner was cheating on me he would discourage me [from being tested]’
‘This will be a good way of testing how much they [husbands] care about us’
Protection
‘We will need to protect ourselves’
‘My husband will get angry if I ask him to wear condoms. He will think I am
doubting him’
Attitudes to HPV testing
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drawing on examples of the limits imposed on abortion, women
visiting male doctors and concerns that cervical screening may
affect unmarried women’s virginity, with Shari’a law
1 identified
as particularly restrictive. However, others felt that Islamic
beliefs would support HPV screening as good for women’s health,
and hence family health. Among the white British women,
taboos surrounding sex within Catholic families were also raised
as potentially restrictive to women participating in HPV testing
(Box 3).
Importance of information about HPV
There was a universal expression of the need for more information
about HPV: ‘many women need to know this information’. The
belief that women ‘should’ have information was forcefully
expressed with a desire for a better understanding of disease risk
and ‘transmission’, to enable women to make ‘choices and changes
in their lifestyles’. The recognition that HPV testing had
implications beyond the individual led to the request for
information to be provided not only for women, but for men
and also the wider community: ‘we need to educate the
community’. It was recognised, in all groups, that clear and
accurate information was critical to everyone’s response to HPV
and the potential impact of HPV testing. The current lack of
accessible information about HPV and its potential to lead to
problems was also raised: ‘ignorance causes many problems’.
DISCUSSION
These findings highlight some of the complex issues that may be
raised by the introduction of HPV testing in cervical screening. A
positive test result was anticipated to lead to considerable anxiety
and distress, and HPV was stigmatised as an STI and associated
with genital warts, which held their own long-standing stigma.
There was confusion between high-risk HPV, genital warts and
other low-risk wart types, and concern about cervical cancer risk
and transmission. This has practical implications for giving
information to women and suggests that the use of the term ‘wart
virus’ to describe high-risk HPV, a common practice among health
professionals, may encourage confusion and exacerbate stigma.
The prospect of testing positive for HPV raised important issues
for women’s relationships in terms of trust, blame, fidelity and
protection through safer sex, and testing had the potential to
communicate unwanted messages to one’s partner, family and the
wider community about trust and sexual behaviour. Concerns were
expressed by women from all of the ethnic groups, but appeared to
be particularly pertinent for some of the Indian and Pakistani
women, for whom sex outside marriage can be strongly pros-
cribed. In such circumstances, HPV infection (or perceived risk of
infection) would have more significant consequences since it could
not be openly attributed to sexual partners encountered prior to
marriage. These findings have serious implications particularly
among some South Asian women, whose chosen sexual lifestyle
may directly impact on their family and wider community
(Bradbury and Williams, 1999; Elam et al, 1999). However, among
all participants, irrespective of ethnic and socioeconomic group,
relationship status and history appeared to play a pivotal role in
the anticipated impact of testing positive for HPV.
Of both practical and theoretical importance, women in all
groups demonstrated confusion about condom use and protection
from HPV. Despite explanations that evidence for the efficacy of
condoms in preventing HPV transmission is uncertain (CDC, 1999;
Carr and Gyorfi, 2000), they were still viewed by some women as
the means to ensure prevention of infection. This suggests that
condoms may be perceived as a method of preventing any STI,
perhaps following HIV health promotion (Gardner et al, 1999).
Health professionals may need to find new ways to communicate
information about the ambiguity surrounding condom use within
the context of HPV prevention.
Despite the anticipated negative consequences of HPV testing,
women from the white British and African-Caribbean groups in
the sample also expressed positive views about testing, and
welcomed the added protection that HPV testing could offer in
terms of cervical cancer prevention. Women from all groups
identified existing information about HPV as inadequate, and
highlighted that the reaction to HPV testing would be determined
by the effectiveness of health information about the virus, its
transmission, latency, prevention and association with CIN. Such
information, while being difficult to communicate, may be critical
to manage the potentially negative impact of HPV.
Our findings have implications for the management of HPV
testing within cervical screening. However it is important to note
that none of the women involved in the study were offered HPV
tests or had previously participated in HPV testing. Women
responded to new information about the link between HPV and
cervical cancer. However, the study is advantaged by its ethnically
heterogeneous sample and the inclusion of older married women,
who have been poorly represented in previous research, but for
whom the impact of HPV may be greater, since they are more
likely to be in long-term monogamous relationships. Previous
work on the psychosocial impact of HPV testing has been
quantitative and sampled young, white, affluent populations, often
American college students (Ramirez et al, 1997; Reed et al, 1999),
and has failed to distinguish psychological outcomes between
those with visible, symptomatic genital warts (low-risk types) and
those with high-risk HPV (Maw et al, 1998). The current study
overcame both these limitations.
Study participants were purposively selected to represent
heterogeneity of attitudes and experiences to HPV and cervical
screening relating to their ethnic, socioeconomic and sexual
relationship background, and this paper sought to illustrate
the key themes that emerged across the sample. As is usual
in qualitative research, participants were not selected to be
statistically representative of their ethnic and socioeconomic
group; rather, they were selected to represent a range of women
eligible for cervical screening so that a diversity of experiences and
attitudes could be covered. Almost all women had participated in
screening previously (93%, n¼66), which compares to 90% within
Box 3 Communicating unwanted messages
Mistrust
‘My partner would see no point [in testing] because he has been my only
partner’ (Indian)
Promiscuity
Women reporting a friend’s experience of an abnormal smear indicating HPV
infection
‘3 weeks of articles in [popular women’s magazine]yvery misleading, saying that
the number of partners you have, you are more or less going to develop
cancerythat was a friend of mine who is now 47 and her mumyhad given her
that articleyshe said you know I had less than 5 partners, I’ve always used
condoms and my mother is thinking I’m a red woman’ (White, British)
Nontraditional beliefs and practices
‘My family would see no point to it as you only have one partner’ (Pakistani)
‘Being single, my family will be suspicious of me [if I go for HPV testing]’
(Pakistani)
1Shari’a (Islamic law) is derived directly from the Qu’ran and sets out a
legal system, which governs individual and social life. The interpretation of
Shari’a principles and practices vary considerably both among and within
Muslim societies and communities.
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review 2002, England). Although some categories of women were
numerically under-represented in the study sample, the full range
of women, and their views, were represented.
Although the study is qualitative and our sample was
purposively selected, its findings may be generalised beyond the
study population (Morse, 1999). The findings suggest that the
psychosocial consequences of HPV testing may be negative for
some women, their partners and families, and this impact may
relate to ethnic, cultural and religious background, and sexual
relationship status and history. Research is now needed to quantify
this impact among representative samples within the UK popula-
tion who are tested for HPV infection. The possible consequences
we observed hold implications not only for the introduction of
HPV testing, but also for current information provision for women
undergoing cervical screening in Britain. Whether HPV testing is
introduced or not, awareness of the association between cervical
cancer and HPV is probably inevitable. Our research identifies a
critical need for accurate information accessible to all ethnic
groups prior to participation in cervical screening. Women clearly
felt that they and, importantly, those around them should have
access to more information about their own risk, managing this
risk and interpreting positive results. The current management of
HPV within cervical screening raises uncomfortable questions
about informed participation in cervical screening and the ethics
of current practices, which seek to maintain high levels of
screening uptake. Our findings add support to the growing
movement towards more informed choice at screening, whether
it be cytology or HPV, as the negative psychosocial costs of
participation could, for some women, be substantial.
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